May 18, 2022 Roth Capital Partners Acted as Sole Agent for Creative Medical Technology (Nasdaq:CELZ) in its $17 Million PIPE Roth Capital Partners
Apr 19, 2022 Roth Capital Partners Acted as Co-Manager for Xponential Fitness, Inc. (NYSE:XPOF) in its $104 Million Follow-On Roth Capital Partners
Mar 10, 2022 Roth Capital Partners Acted as Sole Placement Agent for Applied DNA Sciences (NASDAQ:APDN) in its $4.2 Million Registered Direct Offering Roth Capital Partners
Mar 9, 2022 Roth Capital Partners Acted as Financial Advisor to JustCBD on its Sale to Flora Growth Corp. (Nasdaq:FLGC) Roth Capital Partners
Mar 7, 2022 Roth Capital Partners to Host 34th Annual Conference as In-Person Event March 13-15, 2022 Globe Newswire
Feb 8, 2022 Roth Capital Partners Acted as Sole Placement Agent for Revelation Biosciences Inc. (NASDAQ:REVB) in its $7.8 Million PIPE Offering ROTH Capital Partners
Jan 6, 2022 Roth Capital Partners Acted as Financial Advisor to Pedego on its Investment from Verlinvest Roth Capital Partners
Jan 5, 2022 Roth Capital Partners Acted as Joint Book-Running Manager for Revelstone Capital Acquisition Corp. (Nasdaq:RCACU) in its $150 Million IPO Roth Capital Partners
Dec 21, 2021 Roth Capital Partners Announces the Addition of Mike Niehuser, Managing Director and Senior Research Analyst - Covering Metals & Mining Stocks
